912 related articles for article (PubMed ID: 33631287)
1. Depression and interleukin-6 signaling: A Mendelian Randomization study.
Kelly KM; Smith JA; Mezuk B
Brain Behav Immun; 2021 Jul; 95():106-114. PubMed ID: 33631287
[TBL] [Abstract][Full Text] [Related]
2. The balance of interleukin (IL)-6, IL-6·soluble IL-6 receptor (sIL-6R), and IL-6·sIL-6R·sgp130 complexes allows simultaneous classic and trans-signaling.
Baran P; Hansen S; Waetzig GH; Akbarzadeh M; Lamertz L; Huber HJ; Ahmadian MR; Moll JM; Scheller J
J Biol Chem; 2018 May; 293(18):6762-6775. PubMed ID: 29559558
[TBL] [Abstract][Full Text] [Related]
3. Structure-guided optimization of the interleukin-6 trans-signaling antagonist sgp130.
Tenhumberg S; Waetzig GH; Chalaris A; Rabe B; Seegert D; Scheller J; Rose-John S; Grötzinger J
J Biol Chem; 2008 Oct; 283(40):27200-7. PubMed ID: 18650419
[TBL] [Abstract][Full Text] [Related]
4. Dissecting the Association Between Inflammation, Metabolic Dysregulation, and Specific Depressive Symptoms: A Genetic Correlation and 2-Sample Mendelian Randomization Study.
Kappelmann N; Arloth J; Georgakis MK; Czamara D; Rost N; Ligthart S; Khandaker GM; Binder EB
JAMA Psychiatry; 2021 Feb; 78(2):161-170. PubMed ID: 33079133
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory biomarkers and risk of ischemic stroke and subtypes: A 2-sample Mendelian randomization study.
Lin J; Wang Y; Wang Y; Pan Y
Neurol Res; 2020 Feb; 42(2):118-125. PubMed ID: 31900081
[No Abstract] [Full Text] [Related]
6. Inflammatory Biomarkers and Risk of Schizophrenia: A 2-Sample Mendelian Randomization Study.
Hartwig FP; Borges MC; Horta BL; Bowden J; Davey Smith G
JAMA Psychiatry; 2017 Dec; 74(12):1226-1233. PubMed ID: 29094161
[TBL] [Abstract][Full Text] [Related]
7. Different Soluble Forms of the Interleukin-6 Family Signal Transducer gp130 Fine-tune the Blockade of Interleukin-6 Trans-signaling.
Wolf J; Waetzig GH; Chalaris A; Reinheimer TM; Wege H; Rose-John S; Garbers C
J Biol Chem; 2016 Jul; 291(31):16186-96. PubMed ID: 27226573
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of classic signaling is a novel function of soluble glycoprotein 130 (sgp130), which is controlled by the ratio of interleukin 6 and soluble interleukin 6 receptor.
Garbers C; Thaiss W; Jones GW; Waetzig GH; Lorenzen I; Guilhot F; Lissilaa R; Ferlin WG; Grötzinger J; Jones SA; Rose-John S; Scheller J
J Biol Chem; 2011 Dec; 286(50):42959-70. PubMed ID: 21990364
[TBL] [Abstract][Full Text] [Related]
9. Selective inhibition of IL-6 trans-signaling by a miniaturized, optimized chimeric soluble gp130 inhibits T
Heise D; Derrac Soria A; Hansen S; Dambietz C; Akbarzadeh M; Berg AF; Waetzig GH; Jones SA; Dvorsky R; Ahmadian MR; Scheller J; Moll JM
Sci Signal; 2021 Aug; 14(696):. PubMed ID: 34404751
[TBL] [Abstract][Full Text] [Related]
10. IL-6 trans-signaling system in intra-amniotic inflammation, preterm birth, and preterm premature rupture of the membranes.
Lee SY; Buhimschi IA; Dulay AT; Ali UA; Zhao G; Abdel-Razeq SS; Bahtiyar MO; Thung SF; Funai EF; Buhimschi CS
J Immunol; 2011 Mar; 186(5):3226-36. PubMed ID: 21282511
[TBL] [Abstract][Full Text] [Related]
11. Mendelian Randomization Study on Causal Association of IL-6With Breast Cancer.
Zhang M; Ma N; Wang R
Clin Breast Cancer; 2023 Jun; 23(4):e182-e188. PubMed ID: 36813657
[TBL] [Abstract][Full Text] [Related]
12. Genetically Determined Inflammatory Biomarkers and the Risk of Heart Failure: A Mendelian Randomization Study.
Li X; Peng S; Guan B; Chen S; Zhou G; Wei Y; Gong C; Xu J; Lu X; Zhang X; Liu S
Front Cardiovasc Med; 2021; 8():734400. PubMed ID: 34881299
[No Abstract] [Full Text] [Related]
13. Interleukin-6 and its receptors: a highly regulated and dynamic system.
Wolf J; Rose-John S; Garbers C
Cytokine; 2014 Nov; 70(1):11-20. PubMed ID: 24986424
[TBL] [Abstract][Full Text] [Related]
14. The IL-6-neutralizing sIL-6R-sgp130 buffer system is disturbed in patients with type 2 diabetes.
Aparicio-Siegmund S; Garbers Y; Flynn CM; Waetzig GH; Gouni-Berthold I; Krone W; Berthold HK; Laudes M; Rose-John S; Garbers C
Am J Physiol Endocrinol Metab; 2019 Aug; 317(2):E411-E420. PubMed ID: 31237452
[TBL] [Abstract][Full Text] [Related]
15. Causal relationship of interleukin-6 and its receptor on sarcopenia traits using mendelian randomization.
Chen B; Li S; Lin S; Dong H
Nutr J; 2024 May; 23(1):51. PubMed ID: 38750566
[TBL] [Abstract][Full Text] [Related]
16. Increased levels of IL-6, sIL-6R, and sgp130 in the aqueous humor and serum of patients with diabetic retinopathy.
Chen H; Zhang X; Liao N; Wen F
Mol Vis; 2016; 22():1005-14. PubMed ID: 27563232
[TBL] [Abstract][Full Text] [Related]
17. Association between inflammation and cognition: Triangulation of evidence using a population-based cohort and Mendelian randomization analyses.
Slaney C; Sallis HM; Jones HJ; Dardani C; ; Tilling K; Munafò MR; Davey Smith G; Mahedy L; Khandaker GM
Brain Behav Immun; 2023 May; 110():30-42. PubMed ID: 36791891
[TBL] [Abstract][Full Text] [Related]
18. Mendelian randomization study on causal association of IL-6 signaling with pulmonary arterial hypertension.
Zhang M; Zeng Q; Zhou S; Zhu G; Xu Y; Gao R; Su W; Wang R
Clin Exp Hypertens; 2023 Dec; 45(1):2183963. PubMed ID: 36871578
[TBL] [Abstract][Full Text] [Related]
19. Applying Mendelian randomization to appraise causality in relationships between smoking, depression and inflammation.
Galan D; Perry BI; Warrier V; Davidson CC; Stupart O; Easton D; Khandaker GM; Murray GK
Sci Rep; 2022 Sep; 12(1):15041. PubMed ID: 36057695
[TBL] [Abstract][Full Text] [Related]
20. Dissecting Interleukin-6 Classic and Trans-signaling in Inflammation and Cancer.
Garbers C; Rose-John S
Methods Mol Biol; 2023; 2691():207-224. PubMed ID: 37355548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
